ANDA 61370, held by Chartwell Rx. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 61370 (Ampicillin Trihydrate), held by Chartwell Rx, was first approved by FDA on Aug 3, 1971, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 3, 1971 | Original application | Approved | None posted |
| Ampicillin TrihydrateEQ 125MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Ampicillin TrihydrateEQ 250MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Dec 22, 1997 | Supplement 91Manufacturing | Approved | None posted |
| Aug 28, 1996 | Supplement 90Manufacturing | Approved | None posted |
| Dec 22, 1994 | Supplement 89Manufacturing | Approved | None posted |
| Nov 25, 1991 | Supplement 88Labeling | Approved | None posted |
| Aug 3, 1971 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters